MARC Record from marc_columbia

LEADER: 04846fam a2200433 a 4500
001 4064838
005 20221027030349.0
008 001101s2001 nyuaf b 001 0 eng
010 $a 00053084
020 $a0198506856
035 $a(OCoLC)45320440
035 $a(OCoLC)ocm45320440
035 $9ATE8018HS
035 $a(NNC)4064838
035 $a4064838
040 $aDLC$cDLC$dDLC$dNNC-M$dOrLoB-B
042 $apcc
050 00 $aRC365$b.G58 2001
082 00 $a616.8/0442$221
245 00 $aGlutamine repeats and neurodegenerative diseases :$bmolecular aspects /$cedited by Peter Harper and Max Perutz.
260 $aNew York :$bOxford University Press,$c2001.
300 $axvii, 312 pages, 8 unnumbered pages of color plates :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $a"Edited and updated compilation evolving from a Royal Society discussion meeting"--Cover p. 4.
504 $aIncludes bibliographical references and index.
505 00 $g1.$tHuntington's disease: a clinical, genetic and molecular model for polyglutamine repeat disorders /$rP. S. Harper --$g2.$tA transgenic mouse model of Huntington's disease /$rL. Mangiarini, K. Sathasivian and A. Mahal /$r[et al.] --$g3.$tFrom neuronal inclusions to neurodegeneration: neuropathological investigation of a transgenic mouse model of Huntington's disease /$rS. W. Davies, M. Turmaine and B. A. Cozens /$r[et al.] --$g4.$tBehavioural changes and selective neuronal loss in full-length transgenic mouse models for Huntington's disease /$rP. H. Reddy, V. Charles and W. O. Whetsell /$r[et al.] --$g5.$tEvidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin /$rA. S. Hackam, J. G. Hodgson and R. Singaraja /$r[et al.] --$g6.$tA genetic model for human polyglutamine-repeat disease in Drosophila melanogaster /$rN. M. Bonini --
505 80 $g7.$tPolyglutamine pathogenesis, potential role of protein interactions, proteolytic processing and nuclear localization /$rC. A. Ross, J. D. Wood and M. F. Peters /$r[et al.] --$g8.$tProperties of polyglutamine expansion in vitro and in a cellular model for Huntington's disease /$rA. Lunkes, Y. Trottier and J. Fagart /$r[et al.] --$g9.$tEvidence for a recruitment and sequestration mechanism in Huntington's disease /$rE. Preisinger, B. M. Jordan and A. Kazantsev /$r[et al.] --$g10.$tAggregation of truncated GST-HD exon 1 fusion proteins containing normal range and expanded glutamine repeats /$rB. Hollenbach, E. Scherzinger and K. Schweiger /$r[et al.] --$g11.$tThe localization and interactions of huntingtin /$rA. L. Jones --
505 80 $g12.$tAnalysis of the subcellular localization of huntingtin with a set of rabbit polyclonal antibodies in cultured mammalian cells of neuronal origin: comparison with the distribution of huntingtin in Huntington's disease autopsy brain /$rJ. C. Dorsman, M. A. Smoor and M. L. C. Maat-Schieman /$r[et al.] --$g13.$tAre there multiple pathways in the pathogenesis of Huntington's disease? /$rN. Aronin, M. Kim and G. Laforet /$r[et al.] --$g14.$tCAG repeat instability, cryptic sequence variation and pathogenicity: evidence from different loci /$rM. Frontali, A. Novelletto and G. Annesi /$r[et al.] --$g15.$tMicrosatellite and trinucleotide repeat evolution: evidence for mutational bias and different rates of evolution in different lineages /$rD. C. Rubinsztein, B. Amos and G. Cooper --$g16.$tGenotype-phenotype correlation in the spinocerebellar ataxias /$rP. F. Worth, A. Brice and N. W. Wood --
505 80 $g17.$tInsights from mice carrying X-linked CAG-polyglutamine-repeat mutations /$rJ. M. Ordway, J. A. Cearley and P. J. Detloff --$g18.$tMolecular pathology of dentatorubral-pallidoluysian atrophy /$rIchiro Kanazawa --$g19.$tAndrogen receptor mutation in Kennedy's disease /$rK. H. Fishbeck, A. Lieberman and C. K. Bailey /$r[et al.] --$g20.$tProgress in pathogenesis studies of spinocerebellar ataxia type 1 /$rC. J. Cummings, H. T. Orr and H. Y. Zoghbi --$g21.$tFilamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and [alpla]-synucleinopathies /$rMichael Goedert.
650 0 $aNervous system$xDegeneration$xMolecular aspects.
650 0 $aNervous system$xDegeneration$xGenetic aspects.
650 0 $aGlutamine$xPathophysiology.
650 12 $aNeurodegenerative Diseases$xgenetics.$0https://id.nlm.nih.gov/mesh/D019636Q000235
650 12 $aGlutamine.$0https://id.nlm.nih.gov/mesh/D005973
650 12 $aHuntington Disease.$0https://id.nlm.nih.gov/mesh/D006816
700 1 $aHarper, Peter S.$0http://id.loc.gov/authorities/names/n79075412
700 1 $aPerutz, Max F.$0http://id.loc.gov/authorities/names/n86000363
852 00 $boff,hsl$hRC365$i.G58 2001